Search
for
Sort by
Research 181–210 of 1000+
- Dermatologic Adverse Events from Cancer Treatments
- Dermatologic manifestations of thyroid disease: a literature review
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- Study of the Thyroid Profile of Patients with Alopecia
- Hair Growth After Gefitinib Treatment
- Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer
- Hypothalamic–Pituitary–Thyroid Axis Hormones Stimulate Mitochondrial Function and Biogenesis in Human Hair Follicles
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Impaired Hair Growth and Wound Healing in Mice Lacking Thyroid Hormone Receptors
- Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms via Deep Convolutional Neural Network
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- Cancer-Related Alopecia: From Etiologies to Global Management
- Management of Toxicities of Targeted Therapies
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Recent Advances in Drug Development for Hair Loss
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Amphiregulin in Fibrotic Diseases and Cancer
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Amphiregulin in Fibrotic Diseases and Cancer
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients